A large exercise of company stock options by Jeffrey Dierks, Chief Commercial Officer at Harmony Biosciences (NASDAQ:HRMY) was disclosed in a new SEC filing on September 30, as part of an insider ...
Goldman Sachs & Co. LLC, Jefferies and Piper Sandler acted as lead book-running managers for the offering. This press release shall not constitute an offer to sell or the solicitation of an offer to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback